SEARCH

SEARCH BY CITATION

References

  • 1
    Wahlgren N, Ahmed N, Davalos A et al. Thrombolysis with alteplase 3-4.5 h after acute ischaemic stroke (SITS-ISTR): an observational study. Lancet 2008; 372:13031309.
  • 2
    Hacke W, Kaste M, Bluhmki E et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med 2008; 359:13171329.
  • 3
    Castaño C, Dorado L, Guerrero C et al. Mechanical thrombectomy with the Solitaire AB device in large artery occlusions of the anterior circulation: a pilot study. Stroke 2010; 41:18361840.
  • 4
    Dávalos A, Pereira VM, Chapot R et al. Retrospective multicenter study of solitaire™ fr for revascularization in the treatment of acute ischemic stroke. Stroke 2012; 43:26992705.
  • 5
    Saver JL, Jahan R, Levy EI et al.; SWIFT Trialists. Solitaire flow restoration device versus the Merci Retriever in patients with acute ischaemic stroke (SWIFT): a randomised, parallel-group, non-inferiority trial. Lancet 2012; 380:12411249.
  • 6
    San Román L, Obach V, Blasco J et al. Single-center experience of cerebral artery thrombectomy using the TREVO device in 60 patients with acute ischemic stroke. Stroke 2012; 43:16571659.
  • 7
    Nogueira RG, Lutsep HL, Gupta R et al.; for the TREVO 2 Trialists. Trevo versus Merci retrievers for thrombectomy revascularisation of large vessel occlusions in acute ischaemic stroke (TREVO 2): a randomised trial. Lancet 2012; 380:12321240.
  • 8
    Broussalis E, Trinka E, Hitzl W, Wallner A, Chroust V, Killer-Oberpfalzer M. Comparison of stent-retriever devices versus the merci retriever for endovascular treatment of acute stroke. AJNR Am J Neuroradiol 2013; 34:366372.
  • 9
    Broderick JP, Palesch YY, Demchuk AM et al. Endovascular therapy after intravenous t-PA versus t-PA alone for stroke. N Engl J Med 2013; 368:893903.
  • 10
    Kelly AG, Hoskins KD, Holloway RG. Early stroke mortality, patient preferences, and the withdrawal of care bias. Neurology 2012; 79:941944.
  • 11
    Agresti A (ed.). Analysis of Ordinal Categorical Data, 2nd edn. New York, John Wiley & Sons, 2010.
  • 12
    Whitehead J. Group sequential trials revisited: simple implementation using SAS. Stat Methods Med Res 2011; 20:635656.
  • 13
    Little RJ, D'Agostino R, Cohen ML et al. The prevention and treatment of missing data in clinical trials. N Engl J Med 2012; 367:13551360.